Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Journal Club
Explore
More
Language
English
English
LA
Lana A. Vornik
Immunotherapy and Immune Responses
The University of Texas MD Anderson Cancer Center
Share
Follow
Claim This Profile
About
Research focus
Immunotherapy and Immune Responses
Impact
184 pubs · 2,875 cites · h-index 16
Affiliations
The University of Texas MD Anderson Cancer Center
The University of Texas Health Science Center at Houston
Dartmouth College
See all
Publications
Recent publications by Lana A. Vornik
Time-restricted eating and metformin (TEAM) in invasive breast cancer or DCIS: A randomized, phase IIb, window-of-opportunity presurgical trial.
Journal of Clinical Oncology · Wed,
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial
Nature Medicine · Fri,
Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis
Cancer Prevention Research · Wed,
Supplementary Figure S2 from Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia
Tue,
Supplementary Figure S3 from Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia
Tue,
Data from Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia
Tue,
Supplementary Figure S5 from Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia
Tue,
Supplementary Figure S1 from Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia
Tue,
Supplementary Figure S4 from Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia
Tue,
Supplementary Fig. S1 from Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma in Situ
Mon,